Teladoc Health, Inc. (TDOC) Income Statement

The flat-to-declining revenue base suggests the core virtual care franchise has reached a plateau, with no evidence in these figures of a reacceleration that would offset pricing or utilization pressure. Investors should monitor whether the -3.4% year-over-year decline reflects a structural shift in member volume or a temporary contract timing effect, since the data alone cannot distinguish between the two. Absent a clear new growth driver, the current trajectory implies limited top-line support for valuation.

Stable gross margins around 69% indicate reasonable unit economics in the core service delivery, which is a constructive feature relative to a cost-heavy operating model. The 102.5% reading in 2026Q2 reflects a negative COGS entry of -$15.2M and appears to be an accounting adjustment rather than economic performance, so it warrants further investigation before being relied upon. The gap between gross margin and operating margin is where the analytical concern lies.

With SG&A of $281M against gross profit of $415M in the latest quarter, the cost base absorbs nearly all gross profit, leaving operating losses of -$28.1M. The absence of any quarter with positive operating income suggests the company has not yet demonstrated operating leverage, as overhead has not scaled down meaningfully relative to revenue. This pattern warrants scrutiny of whether cost restructuring can close the gap without further revenue acceleration.